VKTX
Asset Logo

Viking Therapeutics, Inc.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 118.80%
Annual Growth

5 years average annual growth

🌏

6
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The Company is developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRb for X-linked adrenoleukodystrophy (X-ALD), a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells. It is also developing VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the treatment of various metabolic disorders.

📈 Performance

Price History*

+480.29%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$51.53

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in VKTX

6

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

13 weeks

💵 Average investment amount

$1,592

Last time a customer invested in VKTX

1 day
VKTX investor breakdown
💵 Income of investors

More than 200k

17%

150k - 200k

100k - 150k

17%

50k - 100k

50%

Less than 50k

17%
👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

67%

Male

33%

Pearlers who invest in VKTX also invest in...

Novo Nordisk A/S

NVO

🙌 Performance (5Yr p.a)

56.01%

📊 Share price

$102.63 USD
Find Out More

🙌 Performance (5Yr p.a)

538.48%

📊 Share price

$146.67 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

110.72%

📊 Share price

$749.92 USD

🙌 Performance (5Yr p.a)

35.25%

📊 Share price

$412.87 USD

📈 HIGH PRICE GROWTH

📊 Share price

$62.12 USD

Want more shares? Try these...

📊 Share price

$4.70 USD

🙌 Performance (5Yr p.a)

-3.89%

📊 Share price

$9.86 USD
Compare
Add to watchlist